Rational approaches to treating gout

Rational approaches to treating gout

Saved in:

Bibliographic Details
Main Author:	V G Barskova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2008-03-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/138
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

Experience in treating a gout patient with adrenal insufficiency
by: Viktoria Georgiyevna Barskova, et al.
Published: (2012-12-01)

Use of Blemaren citrate formula in gout patients with nephrolithiasis
by: M S Eliseev, et al.
Published: (2008-09-01)

SIGNIFICANCE OF DIET AND DIETARY SUPPLEMENTS IN GOUT
by: A E Il'ina, et al.
Published: (2008-12-01)

Use of citrate formulas in patients with gout and nephrolithiasis
by: F M Kudaeva, et al.
Published: (2007-09-01)

Rational approach to nutrition for patients with gout
by: M. A. Gromova, et al.
Published: (2020-01-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
by: V A Nasonova, et al.
Published: (2007-09-01)

How to optimize treatment in patients with gout and chronic arthritis Urisan is in focus
by: A E Ilyina, et al.
Published: (2009-03-01)

Glomerular filtration rate in patients with gout and factors influencing the rate
by: F M Kudaeva, et al.
Published: (2007-09-01)

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
by: Maksim Sergeyevna Eliseev, et al.
Published: (2014-03-01)

Prevalence and risk f actors influencing the development of arterial hypertension in patients with a gout
by: E. I. Markelova, et al.
Published: (2021-01-01)

The monograph «Behchet's disease» by Z.S. Alekberova
by: V G Barskova, et al.
Published: (2008-03-01)

European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment
by: V G Barskova, et al.
Published: (2011-06-01)

Valentina Aleksandrovna NASONOVA :glazami sovremennikov
by: V G Barskova
Published: (2011-03-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

Gout, hyperuricemy and cardiovascular diseases. Approaches to pharmacotherapy
by: V. V. Tsurko, et al.
Published: (2021-06-01)

Place of topical therapy in rheumatology. Ketoprofen gel is a focus
by: V G Barskova, et al.
Published: (2008-09-01)

Cardiovascular safety of etoricoxib
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)

Management of gout: Primary care approach
by: Olufemi Omole, et al.
Published: (2009-12-01)

Hyperuricemia, gout and comorbidity
by: N. A. Shostak, et al.
Published: (2023-01-01)

Nefrolitiaz u bol'nykh podagroy i pokazaniya k naznacheniyu tsitratnykh smesey
by: F M Kudaeva, et al.
Published: (2008-04-01)

Prospects for using injectable meloxicam (Amelotex®) in patients with osteoarthrosis
by: M S Eliseyev, et al.
Published: (2009-03-01)

USE OF URISAN IN PATIENTS WITH GOUT
by: L A Knyazeva, et al.
Published: (2010-03-01)

Type 2 diabetes mellitus and gout
by: O. V. Zhelyabina, et al.
Published: (2021-10-01)

Estimation of arterial rigidity parameters in patients with gout and essential hypertension
by: E V Klinkova, et al.
Published: (2010-12-01)

RARE CASE OF ESOPHAGUS LESION IN PATTENT WITH BEHCET’S DISEASE
by: V. G. Barskova, et al.
Published: (2001-10-01)

Risk Factors for Gout in Taiwan Biobank: A Machine Learning Approach
by: Liu YR, et al.
Published: (2024-11-01)

Renal filtration function in patients with gout
by: N. N. Kushnarenko, et al.
Published: (2016-09-01)

COLCHICINE IN RHEUMATOLOGY: YESTERDAY AND TODAY. WILL THERE BE TOMORROW?
by: Z S Alekberova, et al.
Published: (2010-06-01)

Gout: possibilities of treatment optimization
by: A. A. Klimenko, et al.
Published: (2024-12-01)

Features of left ventricular remodeling in hypertension patients with comorbid gout
by: I. O. Daniuk, et al.
Published: (2018-10-01)

CHILDHOOD COUGH — RATIONAL APPROACH TO TREATMENT
by: I. M. Kosenko
Published: (2013-02-01)

A rational approach to the treatment of osteoporosis
by: S. Hough
Published: (2007-10-01)

USE OF HERBAL REMEDY URISAN AS BASIC THERAPY FOR GOUT
by: Tamila Nilovna Khalfina, et al.
Published: (2010-06-01)

Artropatiya Sharko: mesto vstrechi revmatologa i endokrinologa
by: F M Kudaeva, et al.
Published: (2010-12-01)

Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)